Responses
Clinical/translational cancer immunotherapy
Original research
Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model
Compose a Response to This Article
Other responses
No responses have been published for this article.
